Development and validation of a LC-MS/MS method based on a new 96-well Hybrid-SPE™-precipitation technique for quantification of CYP450 substrates/metabolites in rat plasma
- 509 Downloads
A rapid and selective high-throughput HESI-LC-MS/MS method for determining eight cytochrome P450 probe drugs in one-step extraction and single run was developed and validated. The four specific probe substrates midazolam, dextromethorphan, tolbutamide, theophylline and their metabolites 1-hydroxymidazolam, dextrorphan, hydroxyl(methyl)tolbutamide, 1,3-dimethyluric acid, together with the deuterated internal standards, were extracted from rat plasma using a novel 96-well Hybrid-SPE™-precipitation technique. The bioanalytical assay was based on reversed phase liquid chromatography coupled with tandem mass spectrometry in the positive ion mode using selected reaction monitoring for drug (-metabolite) quantification. All analytes were separated simultaneously in a single run that lasted less than 11 min. The intra- and inter-day precisions for all eight substrates/metabolites were 1.62–12.81% and 2.09–13.02%, respectively, and the relative errors (accuracy) for the eight compounds ranged from −9.62% to 7.48% and −13.84% to 8.82%. Hence, the present method provides a robust, fast and reproducible analytical tool for the evaluation of four major drug metabolising cytochrome P450 (3A4, 2C9, 1A2 and 2D6) activities with a cocktail approach in rats to clarify herb–drug interactions. The method can be used as a basic common validated high-throughput analytical assay for in vivo interaction studies.
KeywordsHybrid-SPE™ precipitation Validation Phospholipids CYP450
The Austrian Science Fund (FWF) is thanked for the award of an Erwin-Schroedinger scholarship to K. Ardjomand-Woelkart (J2754-B05).
- 3.Boon H, Jurgens T (2001) Drug interactions with natural health products. Health Canada. Available at: http://www.hc-sc.gc.ca/dhp-mps/pubs/complement/interaction_drug-medicament_11-01/index_e.html. Accessed 9 Apr 2008
- 4.Zhang S, Song N, Li Q, Fan H, Liu C (2008) Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats. J Chromatogr B 871:78–89CrossRefGoogle Scholar
- 6.Tomalik-Scharte D, Jetter A, Kinzig-Schippers M, Skott A, Sörgel F, Klaassen T, Kasel D, Harlfinger S, Doroshyenko O, Frank D, Kirchheiner J, Bräter M, Richter K, Gramatte T, Fuhr U (2005) Effect of propiverine on cytochrome P450 enzymes: a cocktail interaction study in healthy volunteers. Drug Metab Dispos 33:1859–1866Google Scholar
- 8.Zhang W, Han F, Guo P, Zhao H, Lin Z, Huang M-Q, Bertelsen K, Weng N (2010) Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS—a high throughput approach to evaluate drug–drug interactions. J Chromatogr B 878:1169–1177CrossRefGoogle Scholar
- 9.Chen Y-L, Junga H, Jiang X, Naidong W (2003) Simultaneous determination of theophylline, tolbutamide, mephenytoin, debrisoquin, and dapsone in human plasma using high-speed gradient liquid chromatography/tandem mass spectrometry on a silica-based monolitihic column. J Sep Sci 26:1509–1519CrossRefGoogle Scholar
- 13.FDA (2001) Guidance for industry: bioanalytical method validation. US Department of Health and Human Services FDA, RockvilleGoogle Scholar